FasL expression in cardiomyocytes activates the ERK1/2 pathway, leading to dilated cardiomyopathy and advanced heart failure.
- Published in:
- Clinical Science, 2016, v. 130, n. 4, p. 289, doi. 10.1042/CS20150624
- By:
- Publication type:
- Article
Works matching IS 01435221 AND DT 2016 AND VI 130 AND IP 4
Results: 7
1
2
Metabolomics screening identifies reduced L-carnitine to be associated with progressive emphysema.
- Published in:
- Clinical Science, 2016, v. 130, n. 4, p. 273, doi. 10.1042/CS20150438
- By:
- Publication type:
- Article
3
Immature myeloid Gr-1<sup>+</sup> CD11b<sup>+</sup> cells from lipopolysaccharide-immunosuppressed mice acquire inhibitory activity in the bone marrow and migrate to lymph nodes to exert their suppressive function.
- Published in:
- Clinical Science, 2016, v. 130, n. 4, p. 259, doi. 10.1042/CS20150653
- By:
- Publication type:
- Article
4
Intra-tumoral IFN-γ -producing Th22 cells correlate with TNM staging and the worst outcomes in pancreatic cancer.
- Published in:
- Clinical Science, 2016, v. 130, n. 4, p. 247, doi. 10.1042/CS20150437
- By:
- Publication type:
- Article
5
Long-term renal and cardiovascular risk after preeclampsia: towards screening and prevention.
- Published in:
- Clinical Science, 2016, v. 130, n. 4, p. 239, doi. 10.1042/CS20150567
- By:
- Publication type:
- Article
6
Renin-angiotensin system as a potential therapeutic target in stroke and retinopathy: experimental and clinical evidence.
- Published in:
- Clinical Science, 2016, v. 130, n. 4, p. 221, doi. 10.1042/CS20150350
- By:
- Publication type:
- Article
7
Annexin A1 localization and its relevance to cancer.
- Published in:
- Clinical Science, 2016, v. 130, n. 4, p. 205, doi. 10.1042/CS20150415
- By:
- Publication type:
- Article